ES2775789T3 - Nuevos derivados de piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados de piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen Download PDF

Info

Publication number
ES2775789T3
ES2775789T3 ES17727927T ES17727927T ES2775789T3 ES 2775789 T3 ES2775789 T3 ES 2775789T3 ES 17727927 T ES17727927 T ES 17727927T ES 17727927 T ES17727927 T ES 17727927T ES 2775789 T3 ES2775789 T3 ES 2775789T3
Authority
ES
Spain
Prior art keywords
group
methyl
pyrimidin
pyrrolo
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17727927T
Other languages
English (en)
Spanish (es)
Inventor
András Kotschy
Csaba Weber
Attila Vasas
Balázs Molnar
Arpád Kiss
Alba Macias
James Brooke Murray
Elodie Lewkowicz
Olivier Geneste
Maïa Chanrion
Didier Demarles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Vernalis R&D Ltd
Original Assignee
Laboratoires Servier SAS
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS, Vernalis R&D Ltd filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of ES2775789T3 publication Critical patent/ES2775789T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES17727927T 2016-06-10 2017-06-09 Nuevos derivados de piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen Active ES2775789T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2017/064067 WO2017212012A1 (en) 2016-06-10 2017-06-09 New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ES2775789T3 true ES2775789T3 (es) 2020-07-28

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17727927T Active ES2775789T3 (es) 2016-06-10 2017-06-09 Nuevos derivados de piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen

Country Status (46)

Country Link
US (1) US11046681B2 (enExample)
EP (1) EP3468974B1 (enExample)
JP (1) JP6928005B2 (enExample)
KR (1) KR20190016106A (enExample)
CN (1) CN109311888B (enExample)
AR (1) AR108706A1 (enExample)
AU (1) AU2017277734B2 (enExample)
BR (1) BR112018075433A2 (enExample)
CA (1) CA3027014C (enExample)
CL (1) CL2018003474A1 (enExample)
CO (1) CO2018013210A2 (enExample)
CR (1) CR20180564A (enExample)
CU (1) CU20180145A7 (enExample)
CY (1) CY1122870T1 (enExample)
DK (1) DK3468974T3 (enExample)
DO (1) DOP2018000270A (enExample)
EA (1) EA037211B1 (enExample)
EC (1) ECSP18090144A (enExample)
ES (1) ES2775789T3 (enExample)
FR (1) FR3052452B1 (enExample)
GE (1) GEP20207160B (enExample)
HR (1) HRP20200361T1 (enExample)
HU (1) HUE049507T2 (enExample)
IL (1) IL263463B (enExample)
LT (1) LT3468974T (enExample)
MA (1) MA45222B1 (enExample)
MD (1) MD3468974T2 (enExample)
ME (1) ME03670B (enExample)
MX (1) MX374794B (enExample)
MY (1) MY196562A (enExample)
NI (1) NI201800132A (enExample)
NZ (1) NZ748946A (enExample)
PE (1) PE20220567A1 (enExample)
PH (1) PH12018502515B1 (enExample)
PL (1) PL3468974T3 (enExample)
PT (1) PT3468974T (enExample)
RS (1) RS60029B1 (enExample)
RU (1) RU2743163C2 (enExample)
SG (1) SG11201810629QA (enExample)
SI (1) SI3468974T1 (enExample)
SV (1) SV2018005791A (enExample)
TN (1) TN2018000410A1 (enExample)
TW (1) TWI620750B (enExample)
UA (1) UA123794C2 (enExample)
UY (1) UY37288A (enExample)
WO (1) WO2017212012A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069488B (zh) 2016-03-07 2021-09-07 英安塔制药有限公司 乙型肝炎抗病毒剂
CA3060416A1 (en) 2017-04-21 2018-10-25 Epizyme, Inc. Combination therapies with ehmt2 inhibitors
TWI811236B (zh) 2017-08-28 2023-08-11 美商因那塔製藥公司 B型肝炎抗病毒試劑
EA202091260A1 (ru) 2017-11-29 2020-09-07 Ле Лаборатуар Сервье Новые пиперидинильные производные в качестве ингибиторов убиквитин-специфической протеазы 7
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
US10865211B2 (en) 2018-09-21 2020-12-15 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
US11198693B2 (en) 2018-11-21 2021-12-14 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
BR112021010644A2 (pt) * 2018-12-06 2021-09-28 Almac Discovery Limited Composto, estereoisômero, tautômero, hidrato, derivado de n-óxido ou sal farmaceuticamente aceitável, composição farmacêutica, métodos para tratamento de obesidade, resistência a insulina, diabetes tipo ii, atrofia muscular e câncer e para redução de perda de massa muscular em um indivíduo, e, inibidor de usp19
US11236111B2 (en) 2019-06-03 2022-02-01 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
WO2020247561A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US11236108B2 (en) 2019-09-17 2022-02-01 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
US11802125B2 (en) 2020-03-16 2023-10-31 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2634235A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant
EP2136805A2 (en) * 2007-03-02 2009-12-30 Schering Corporation Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
AR103297A1 (es) * 2014-12-30 2017-05-03 Forma Therapeutics Inc Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
MD3468971T2 (ro) * 2016-06-10 2020-06-30 Servier Lab Noi derivați de piperidinil (hetero)aril-substituiţi, procedeu de obţinere a acestora și compoziții farmaceutice care îi conțin

Also Published As

Publication number Publication date
MY196562A (en) 2023-04-19
CN109311888A (zh) 2019-02-05
PH12018502515B1 (en) 2021-11-10
CR20180564A (es) 2019-03-04
CN109311888B (zh) 2021-09-14
DK3468974T3 (da) 2020-05-11
MA45222B1 (fr) 2020-04-30
CL2018003474A1 (es) 2019-05-24
TN2018000410A1 (en) 2020-06-15
LT3468974T (lt) 2020-04-10
UA123794C2 (uk) 2021-06-02
PL3468974T3 (pl) 2020-07-13
RU2018147430A3 (enExample) 2020-07-10
US20190144448A1 (en) 2019-05-16
EP3468974B1 (en) 2020-02-12
GEP20207160B (en) 2020-10-12
AR108706A1 (es) 2018-09-19
CA3027014A1 (en) 2017-12-14
UY37288A (es) 2018-01-02
JP2019517556A (ja) 2019-06-24
HUE049507T2 (hu) 2020-09-28
SV2018005791A (es) 2019-01-16
KR20190016106A (ko) 2019-02-15
US11046681B2 (en) 2021-06-29
RU2018147430A (ru) 2020-07-10
CA3027014C (en) 2021-01-05
TWI620750B (zh) 2018-04-11
JP6928005B2 (ja) 2021-09-01
IL263463B (en) 2021-01-31
FR3052452B1 (fr) 2018-06-22
FR3052452A1 (enExample) 2017-12-15
MD3468974T2 (ro) 2020-05-31
PT3468974T (pt) 2020-03-25
EP3468974A1 (en) 2019-04-17
SI3468974T1 (sl) 2020-07-31
SG11201810629QA (en) 2018-12-28
PE20220567A1 (es) 2022-04-13
CU20180145A7 (es) 2019-07-04
TW201802092A (zh) 2018-01-16
CO2018013210A2 (es) 2018-12-28
CY1122870T1 (el) 2021-05-05
PH12018502515A1 (en) 2019-09-30
EA201892838A1 (ru) 2019-06-28
ECSP18090144A (es) 2019-01-31
NZ748946A (en) 2025-06-27
MX374794B (es) 2025-03-06
RU2743163C2 (ru) 2021-02-15
HRP20200361T1 (hr) 2020-06-12
IL263463A (en) 2019-01-31
DOP2018000270A (es) 2019-05-15
NI201800132A (es) 2019-04-08
WO2017212012A1 (en) 2017-12-14
MA45222A (fr) 2019-04-17
AU2017277734B2 (en) 2021-07-01
EA037211B1 (ru) 2021-02-19
AU2017277734A1 (en) 2018-12-20
BR112018075433A2 (pt) 2019-03-19
MX2018015216A (es) 2019-04-25
ME03670B (en) 2020-10-20
RS60029B1 (sr) 2020-04-30

Similar Documents

Publication Publication Date Title
ES2775789T3 (es) Nuevos derivados de piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
KR102724968B1 (ko) Shp2 억제제 및 이의 용도
CN114423756B (zh) 取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
CA3027008C (en) (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
US10016438B2 (en) Bicyclic heterocycles as FGFR4 inhibitors
ES2935746T3 (es) Inhibidores de desmetilasa-1 específica de lisina
ES2488966T3 (es) Inhibidores de cinasa de tipo Polo
CA3083320C (en) Piperidinyl derivatives as inhibitors of ubiquitin specific protease 7
HK40004049A (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
OA19084A (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them.
HK40007201B (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
HK40007201A (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them